São Paulo, June 05, 2017 - Rodrigo Lorca takes office, from the next month, the position of Director of Primary Care Business Unit, reporting to Fernando Almeida, President of Chiesi do Brasil. He will lead the Marketing and the Sales Force areas of the segment.
Graduated in Electric Engineering with focus on Digital Systems and Computers at USP, Rodrigo Lorca also has a Marketing Executive MBA at the same institution and has a solid experience in the pharmaceutical industry.
Lorca has worked in companies such as Janssen, Roche and AstraZeneca in positions of Business Unit Director of Oncology, Immunology and Pain. He was also responsible for the development and execution of action plans to expand access to public market, new products release preparation, restructuring of oncology, immunology lines, among other activities.
He also had the opportunity to work as General Manager at Eisai Laboratórios Brasil, where he was responsible for the startup release in the country.
Chiesi, an ethical pharmaceutical company, with over 80 years dedicated to research and development of medicine and new technologies, today is one of the main pharmaceutical industries in Europe, relying on a wide range of products in several therapeutic segments. Based in Parma, Italy, the group operates in all continents, with 26 direct branches, three production plants (Italy, France and Brazil) and four research and development center for new products and technologies (Italy, France, United States and England).
The Chiesi Farmacêutica Brazilian subsidiary is responsible for the company industrial and commercial operations in our country since 1976, contributing to the commercial balance by exporting approximately 25% of its annual production to Europe, North Africa and Pakistan, offering to the Brazilian health professional and patients a quality and reliability acknowledged all over the world.
Currently, Chiesi Group has over 4 thousand employees all over the world, where approximately 350 are in Brazil and, 140 of them are exclusively dedicated to scientific disclosure for over 22 thousand physicians in the country.
For more information, please visit www.chiesi.com.br